Moderna CEO pushes for second COVID-19 booster shot, but doctors aren't yet convinced it's necessary
Fox News
During its third-quarter earnings results report, Moderna said commercial booster market sales could be up to $2 billion in the United States in 2022.
"I still believe we’re going to need boosters in the fall of ’22 and forward," Bancel said.
The announcement follows data from Israel that noted a fourth COVID-19 booster produced a five-fold increase in antibodies just one week after administering the shot. Bancel said the company had started working on a vaccine tailored to the omicron variant, but any such shot would not be available in the next few months, Reuters reported.
But with first boosters only just administered to most eligible adults, data remains light on the actual efficacy or loss of efficacy of the shots, and the Israel study only noted an increase in antibodies and did not say anything about efficacy.